Arax Advisory Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-165
| Closed | -$2.86K | – | 2732 |
|
|
2024
Q4 | $2.86K | Hold |
165
| – | – | ﹤0.01% | 1921 |
|
|
2024
Q3 | $3.06K | Buy |
+165
| New | +$3.06K | ﹤0.01% | 1911 |
|
|
2018
Q4 | $43K | Sell |
728
-27
| -4% | -$1.6K | 0.02% | 287 |
|
|
2018
Q3 | $87K | Buy |
755
+28
| +4% | +$3.23K | 0.04% | 218 |
|
|
2018
Q2 | $91K | Buy |
727
+368
| +103% | +$46.1K | 0.04% | 168 |
|
|
2018
Q1 | $38K | Sell |
359
-95
| -21% | -$10.1K | 0.02% | 226 |
|
|
2017
Q4 | $49K | Sell |
454
-2
| -0.4% | -$216 | 0.02% | 214 |
|
|
2017
Q3 | $45K | Hold |
456
| – | – | 0.02% | 223 |
|
|
2017
Q2 | $46K | Buy |
456
+17
| +4% | +$1.72K | 0.02% | 237 |
|
|
2017
Q1 | $50K | Buy |
439
+63
| +17% | +$7.18K | 0.02% | 206 |
|
|
2016
Q4 | $45K | Buy |
+376
| New | +$45K | 0.02% | 180 |
|